Selected article for: "anti coronaviral infection drug target and P1 position"

Author: Jo, Seri; Kim, Suwon; Shin, Dong Hae; Kim, Mi-Sun
Title: Inhibition of SARS-CoV 3CL protease by flavonoids
  • Document date: 2019_11_14
  • ID: vynk8q8c_2
    Snippet: SARS-and MERS-CoVs genomes contain two open reading frames ORF1a and ORF1b translated to two respective viral polyproteins pp1a and pp1ab by host ribosomes. ORF1a encodes two cysteine proteases, a papain-like protease (PLpro) and a 3C-like protease (3CLpro). While PLpro cuts the first three cleavage sites of its polyprotein, 3CLpro is responsible for cleavage of the remaining 11 locations resulting in release of a total of 16 nonstructural protei.....
    Document: SARS-and MERS-CoVs genomes contain two open reading frames ORF1a and ORF1b translated to two respective viral polyproteins pp1a and pp1ab by host ribosomes. ORF1a encodes two cysteine proteases, a papain-like protease (PLpro) and a 3C-like protease (3CLpro). While PLpro cuts the first three cleavage sites of its polyprotein, 3CLpro is responsible for cleavage of the remaining 11 locations resulting in release of a total of 16 nonstructural proteins (nsp) in both SARS-and MERS-CoVs. The homodimeric form of 3CLpro is active in the presence of substrates. The crystal structures of both 3CLpros showed that each monomer is composed of three structural domains: domains I and II form a chymotrypsin-like architecture with a catalytic cysteine and are connected to a third C-terminal domain via a long loop 10 . In the proteolytic site, all 3CLpros prefer glutamine at P1 position and leucine, basic residues, small hydrophobic residues at P2, P3 and P4 positions, respectively 11 . At P1 0 and P2 0 positions, small residues are required. However, P3 0 position shows no strong preference. Since the autocleavage process is essential for viral propagation, 3CLpro is a good drug target for anti-coronaviral infection.

    Search related documents:
    Co phrase search for related documents
    • anti coronaviral infection and drug target: 1
    • anti coronaviral infection and good anti coronaviral infection drug target: 1
    • anti coronaviral infection drug target and autocleavage process: 1
    • anti coronaviral infection drug target and drug target: 1
    • anti coronaviral infection drug target and good anti coronaviral infection drug target: 1
    • autocleavage process and drug target: 1
    • autocleavage process and good anti coronaviral infection drug target: 1
    • basic residue and cleavage site: 1, 2, 3
    • basic residue and hydrophobic residue: 1, 2, 3
    • catalytic cysteine and cleavage site: 1, 2, 3, 4, 5, 6
    • catalytic cysteine and crystal structure: 1, 2, 3, 4
    • catalytic cysteine and cysteine protease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • catalytic cysteine and drug target: 1, 2, 3, 4
    • catalytic cysteine and hydrophobic residue: 1
    • cleavage site and crystal structure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cleavage site and cysteine protease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • cleavage site and drug target: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • cleavage site and hydrophobic residue: 1, 2, 3
    • crystal structure and cysteine protease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24